The new consolidated purchasing scheme presented by President Claudia Sheinbaum Pardo, in order to guarantee the supply of medicines for the coming years, It lacks transparency and will generate a premium for the Mexican State, stated members of the pharmaceutical industry.
In a document delivered to senators from various parties, they stated that by closing the tender to some laboratories and centralizing the purchases of 4,498 keys required in the Health Sector, the risk of adequately supplying medicines and medicines throughout the country will worsen. healing material, because if the laboratories do not have the supplies to produce the medicines, delivery times will be complicated.
“We have been reiterating it, this tender will affect people, because if you have a small number of laboratories with large production of medicines, a few companies will benefit and the ghost of the most influential in the Fourth Transformation will be present,” they explained to senators from opposition.
“In addition, it is not specified whether these laboratories have the infrastructure to guarantee the quality and delivery of the products,” is indicated in the analysis presented by members of the pharmaceutical industry.
They stressed that the industry is in the best position to help President Claudia Sheinbaum to put an end to the numerous failed attempts of the previous six-year terms to guarantee the supply of medicines through the maximum participation of companies in the field and thereby respond to the complaints from patients throughout the country.
Last week, the president presented the New Consolidated Contracting Model for Medicines and Medical Supplies, for the period 2025 – 2026, which she said will have an investment of 130 billion pesos. with the purpose of making more efficient, transparent and guaranteeing the supply of medicines and materials necessary in the health sector.
“It is a very important purchase for Mexicans’ access to health. The way in which it will be done, in a transparent manner, inviting everyone who has to do with health care to participate. So: transparency, zero corruption and a scheme in which all institutions participate,” said Claudia Sheinbaum.
He highlighted that with this new model, the digitalization of procedures is a fundamental axis, and The portal was presented for the dissemination and public discussion of “Consolidated purchases of medicines and medical supplies in the health sector, where you can consult, analyze and make proposals.”
AMLO was left to owe to the pharmacists
The administration of former president Andrés Manuel López Obrador (AMLO) was left to owe two thousand 900 million pesos to the pharmaceutical industry for medicines and equipment that it acquired through the Institute of Health for Wellbeing (Knowledge).
That organization disappeared in 2023, but it was not able to settle all the contracts with the laboratories from which it had requested material, so they are now negotiating payment with the government of President Claudia Sheinbaum Pardo.
